Hospital Acquired Infection Control Market

Hospital Acquired Infection Control Market Value to Reach US$ 7,580.8 Mn in 2025, e
According to a newly published report by Persistence Market Research titled “Hospital Acquired
Infections (HAIs) Control Market: Global Industry Analysis (2012-2016) and Forecast (20172025),” sales of hospital acquired infections control equipment is expected to be valued at US$
5,450.6 Mn in 2018 and this is likely to increase to US$ 7,580.8 Mn in 2025, expanding at a CAGR
of 4.8% during the study period. This report tracks the performance of the global hospital acquired
infections control market for a period of eight years between 2017 and 2025. A growing prevalence
of hospital acquired infections across the globe, rising awareness and demand for new and
improved hospital acquired infections treatment modalities, and a rapidly expanding healthcare
infrastructure are some of the driving factors of the global hospital acquired infections control
market.
Hospital Acquired Infection Control Market Research Report Overview @
https://www.persistencemarketresearch.com/market-research/hospital-acquired-infection-controlmarket.asp
Reported adverse events from failure of endoscope reprocessing to hinder market growth ,Excise
duty imposed on medical device manufacturers would reduce profit margins ,High cost of
technology hampering revenue growth of the hospital acquired infections control market
,Inadequate reimbursement policies to restrain market growth ,Delayed reprocessing and lack of
clarity of instruction is a challenge ,Stringent rules and regulations to hamper the growth rate of the
global market , Low awareness of endoscope reprocessing in developing countries is another
restraint Lack of proper healthcare infrastructure in emerging markets is also restricting revenue
growth of the global market.
Request Sample [email protected] https://www.persistencemarketresearch.com/samples/2814
On the basis of product type, the global hospital acquired infections control market is segmented
into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization
equipment, and disinfection equipment. In terms of revenue, disinfection equipment was the
dominant product type in the global hospital acquired infections control market in 2016. In terms of
growth, low temperature sterilization equipment is expected to be the fastest growing segment,
registering a CAGR of 5.3% over the forecast period.
Global Hospital Acquired Infections Control Market: Forecast by End User
On the basis of end user, the global market for hospital acquired infections control is segmented into
hospitals, ambulatory surgery centers, medical institutions, diagnostic laboratories and clinics.
Hospitals dominated the global hospital acquired infections control market in revenue terms in
2016, and the trend is projected to continue throughout the forecast period. Hospitals are expected
to be the most lucrative among all end users, with a market attractiveness index of 1.6.
Download and View Report TOC, Figures and Tables @
https://www.persistencemarketresearch.com/market-research/hospital-acquired-infection-controlmarket/toc
Five regional markets namely North America, Latin America, Europe, APAC and MEA are studied
in this report. North America dominated the global hospital acquired infections control market in
revenue terms in 2016 and is projected to continue to do so throughout the forecast period. North
America is anticipated to be the most attractive regional market with an attractiveness index of 1.7
during the forecast period. Acceptance of newly developed therapeutic procedures in bacterial
infections are expected to continue to provide future growth opportunities in the North America
hospital acquired infections control market.
Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc.,
Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co.,
Inc., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories,
Bayer AG, Alere Inc., The 3M Company and Cepheid Inc. are some of the key players operating in
the global hospital acquired infections control market.
Get Full Report now @ https://www.persistencemarketresearch.com/checkout/2814